--- title: "Leon: Jiuyi steadily completed a reduction of 1.0000%" type: "News" locale: "en" url: "https://longbridge.com/en/news/252653559.md" description: "Leon announced that its shareholder, Jiuyi Stable Growth No. 1 Private Securities Investment Fund, holding more than 5% of shares, has reduced its holdings by 4.6029 million shares through centralized bidding transactions from May 23, 2025, to August 11, 2025, at an average reduction price of 10.92 yuan/share, accounting for 1.0000% of the company's total share capital; after the reduction, it holds 18.6471 million shares, accounting for 4.0511%. The reduction plan has been completed, consistent with previous disclosures" datetime: "2025-08-12T10:45:10.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/252653559.md) - [en](https://longbridge.com/en/news/252653559.md) - [zh-HK](https://longbridge.com/zh-HK/news/252653559.md) --- # Leon: Jiuyi steadily completed a reduction of 1.0000% Leon announced that its shareholder, Jiuyi Stable Growth No. 1 Private Securities Investment Fund, which holds more than 5% of the shares, has reduced its holdings by 4.6029 million shares through centralized bidding transactions from May 23, 2025, to August 11, 2025, at an average reduction price of 10.92 yuan per share, accounting for 1.0000% of the company's total share capital. After the reduction, it holds 18.6471 million shares, accounting for 4.0511%. The reduction plan has been completed, consistent with previous disclosures ### Related Stocks - [300603.CN](https://longbridge.com/en/quote/300603.CN.md) ## Related News & Research - [Coffee Prices Rebound on Technical Short-Covering](https://longbridge.com/en/news/286941721.md) - [AI Agent Isolation Model and Security Boundary from a System Perspective](https://longbridge.com/en/news/287033210.md) - [The Intersection Between Technical Analysis and Commodity Futures Spreads](https://longbridge.com/en/news/287043412.md) - [15:41 ETMoonRay, DreamWorks Animation's Open Source Production Renderer, Joins the Academy Software Foundation](https://longbridge.com/en/news/286958326.md) - [20:00 ETAccro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases](https://longbridge.com/en/news/286830151.md)